Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Mar 18, 2013

Bioserv and Advantar Target a Comprehensive Value Chain

  • Bioserv signed a nonexclusive collaboration agreement with Advantar Laboratories to combine each firm’s capabilities for the creation of an improved value chain for client companies. Specifically, Bioserv will partner with Advantar Laboratories to offer its customers a portfolio of integrated service offerings.

    “The Bioserv-Advantar alliance [will provide] access to early formulation and analytical method development expertise, plus high-quality aseptic and non-aseptic manufacturing of liquids, powders, gels, and lyophilized drug products,” said Al Hansen, chairman and CEO of Bioserv. “The Bioserv-Advantar alliance will also provide its customers with labeling, kitting, storage, and shipment services. Our collaboration creates multiple synergies that will benefit customers in terms of quality, timeliness, and cost-effectiveness. It is truly a ‘win-win’ for both organizations.”

    Bioserv is engaged in pharmaceutical cGMP contract manufacturing, clinical packaging, and cold chain and distribution services, while Advantar brings analytical testing, biophysical characterization, drug product formulation, and litigation support services to the table.

Related content


GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

What Does Brexit Mean for Biotech?

Do you agree with the contention that Brexit will NOT have a long-term negative impact on the British biotech industry?

More »